InvestorsHub Logo
Followers 38
Posts 6909
Boards Moderated 1
Alias Born 09/06/2014

Re: guardiangel post# 25285

Thursday, 09/18/2014 8:28:19 AM

Thursday, September 18, 2014 8:28:19 AM

Post# of 30046
DR70 is off patent -- if Fortis wants DR70 they have it right now and they don't have to pay Radient a penny in royalties or licensing fees. Remember the argument that Provista had some kind of non-compete clause with Radient that prevented them from using DR70 for five years? SRL has no such clause because SRL never signed anything with Radient.

If Fortis is taking over Radient, where are the Fortis Schedule 13D's? Fortis is a big company -- I seriously doubt they are playing a cat-and-mouse game of "silent partners" and "hidden 4.99% buyout groups." If Fortis wanted Radient they'd snap their fingers and make it so. The odds of anyone taking over Radient now are poor, but the odds of Fortis taking over Radient are astronomically poor.

19 out of 20 developmental biotechs fail. IMO it's absurd to say that Radient is the 1-in-20 that succeeds after the company declared itself insolvent, revoked its shares, and lost all patent protection for its one marginally marketable product.


Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.